Enavlo Expands Into MENA Market With Major Diabetes Drug Deal
Daewoong Pharmaceutical Expands Enavogliflozin Reach Across MENA Markets South Korean pharmaceutical firm Daewoong Pharmaceutical has secured a contract to export its proprietary SGLT-2 inhibitor, Enavogliflozin, to the Middle East and ... Read More